December 23, 2004
Submitted by Mail
    Centers for Medicare & Medicaid Services
    Department of Health & Human Services
    P.O. Box 8012
    Baltimore, MD 21244-8012
    Attention: CMS-1429-FC
Re: Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2005 [CMS-1429-FC]
To Whom It May Concern:
As organizations involved in cancer treatment, research and patient advocacy, we commend the Centers for Medicare & Medicaid Services (CMS), and you personally, for the recent announcement of a one-year demonstration project to assess quality care for Medicare patients undergoing chemotherapy. This project provides important near-term support for necessary provider services associated with delivery of cancer chemotherapy, but also establishes a foundation for longer term assessment of the needs of cancer patients and the best means of addressing those needs.
In this major 
    new initiative, we applaud your willingness to consult with thought leaders 
    in the provider and patient communities to assure that the assessment tools 
    are most appropriate to the circumstances. A year's worth of well-designed 
    data collection will represent a significant first step toward the sort of 
    information collection that is required to measure quality cancer care, but 
    we would hope that CMS also would be open to extension of the one-year project 
    beyond 2005 in order to move toward a permanent information gathering system. 
    In addition, there may be other information elements that should be collected 
    and assessed for future applications, including, for example, potential coding 
    and reimbursement for chemotherapy management of oral anticancer agents that 
    are increasingly an integral part of modern cancer care.
    
    We deeply appreciate the thoughtful approaches that you have brought to the 
    often difficult topic of reimbursement for cancer chemotherapy services, and 
    we believe that this demonstration project will prove to be the beginning 
    of a new paradigm of quality measurement for cancer care. Thanks very much 
    for your involvement.
Sincerely,
    Cancer Leadership Council
    
    American Cancer Society
    American Society of Clinical Oncology
    American Society for Therapeutic Radiology & Oncology, Inc.
    Cancer Research and Prevention Foundation
    The Children's Cause for Cancer Advocacy
    Coalition of National Cancer Cooperative Groups
    International Myeloma Foundation
    Kidney Cancer Association
    The Leukemia & Lymphoma Society
    Lymphoma Research Foundation
    National Coalition for Cancer Survivorship
    North American Brain Tumor Coalition
    Ovarian Cancer National Alliance
    Pancreatic Cancer Action Network
    Sarcoma Foundation of America
    The Susan G. Komen Breast Cancer Foundation
    Us Too International Prostate Cancer Education and Support Network
    Y-ME National Breast Cancer Organization